Fidelity Investments’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.11M Sell
983,001
-6,411,161
-87% -$7.24M ﹤0.01% 2683
2025
Q1
$10.8M Sell
7,394,162
-16,377,833
-69% -$23.9M ﹤0.01% 1882
2024
Q4
$50.6M Sell
23,771,995
-6,254,961
-21% -$13.3M ﹤0.01% 1376
2024
Q3
$84.1M Sell
30,026,956
-1,230,644
-4% -$3.45M 0.01% 1173
2024
Q2
$72.8M Buy
31,257,600
+5,893,802
+23% +$13.7M ﹤0.01% 1163
2024
Q1
$113M Buy
25,363,798
+122,299
+0.5% +$547K 0.01% 1005
2023
Q4
$81M Buy
25,241,499
+97,568
+0.4% +$313K 0.01% 1094
2023
Q3
$79.7M Buy
25,143,931
+225,976
+0.9% +$716K 0.01% 1066
2023
Q2
$124M Buy
24,917,955
+23,548,101
+1,719% +$117M 0.01% 902
2023
Q1
$6.77M Sell
1,369,854
-187,877
-12% -$928K ﹤0.01% 2009
2022
Q4
$9.8M Buy
1,557,731
+328,073
+27% +$2.06M ﹤0.01% 1901
2022
Q3
$13.3M Sell
1,229,658
-91,236
-7% -$985K ﹤0.01% 1778
2022
Q2
$15.1M Buy
1,320,894
+197,226
+18% +$2.25M ﹤0.01% 1775
2022
Q1
$10.2M Sell
1,123,668
-751,808
-40% -$6.85M ﹤0.01% 2114
2021
Q4
$28M Buy
1,875,476
+966,226
+106% +$14.4M ﹤0.01% 1663
2021
Q3
$23.4M Buy
909,250
+245,401
+37% +$6.31M ﹤0.01% 1768
2021
Q2
$17.3M Buy
663,849
+98,358
+17% +$2.57M ﹤0.01% 1899
2021
Q1
$20M Buy
565,491
+69
+0% +$2.44K ﹤0.01% 1806
2020
Q4
$14.3M Sell
565,422
-732,429
-56% -$18.5M ﹤0.01% 1845
2020
Q3
$48.9M Sell
1,297,851
-1,614,626
-55% -$60.9M ﹤0.01% 1202
2020
Q2
$125M Sell
2,912,477
-658,435
-18% -$28.2M 0.01% 790
2020
Q1
$69.4M Sell
3,570,912
-1,290,054
-27% -$25.1M 0.01% 905
2019
Q4
$126M Sell
4,860,966
-670,918
-12% -$17.4M 0.01% 829
2019
Q3
$151M Sell
5,531,884
-101,049
-2% -$2.75M 0.02% 734
2019
Q2
$151M Sell
5,632,933
-567,610
-9% -$15.2M 0.02% 750
2019
Q1
$178M Buy
6,200,543
+1,289,556
+26% +$37.1M 0.02% 684
2018
Q4
$130M Buy
+4,910,987
New +$130M 0.02% 737